NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.
Also ASCO to release abstracts to members prior to annual meeting.
Advisors suggest NCI establish sarcoma research consortium.
Lung cancer screening trial reaches accrual goal of 50,000.
Markison leaving Bristol-Myers, two others promoted in reorganization.
Wilding named director, Univ. of Wisconsin Cancer Center.
NABCO to close June 30.
This month’s 8-page Business & Regulatory Report included in this issue.
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies